AACP
HALO icon

Advantage Alpha Capital Partners’s Halozyme HALO Stock Holding History

Advantage Alpha Capital Partners’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,466
Closed -$621K – 53
2025
Q3 		$621K Sell
8,466
-1,567
-16% -$104K 0.19% 102
2025
Q2 		$522K Sell
10,033
-3,797
-27% -$216K 0.14% 95
2025
Q1 		$882K Buy
13,830
+4,797
+53% +$279K 0.22% 87
2024
Q4 		$432K Sell
9,033
-5,705
-39% -$293K 0.1% 134
2024
Q3 		$844K Sell
14,738
-9,768
-40% -$560K 0.19% 95
2024
Q2 		$1.28M Sell
24,506
-2,573
-10% -$113K 0.28% 83
2024
Q1 		$1.1M Sell
27,079
-2,838
-9% -$106K 0.21% 96
2023
Q4 		$1.11M Buy
+29,917
New +$1.13M 0.21% 99

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Advantage Alpha Capital Partners's HALO Position: Q4 2025 in Review

Advantage Alpha Capital Partners sold out of Halozyme (HALO) in Q4 2025, closing a stake of 8,466 shares — an estimated $621K sold.

Advantage Alpha Capital Partners first reported a position in HALO in Q4 2023 and held it in 8 quarters. The position peaked at $1.28M in Q2 2024. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Advantage Alpha Capital Partners reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 8,466 Halozyme shares in Q4 2025, an estimated $621K.
  • Advantage Alpha Capital Partners first reported a position in Halozyme in Q4 2023 and held it in 8 quarters.
  • Advantage Alpha Capital Partners's Halozyme position peaked at $1.28M in Q2 2024.
  • 617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2025.